Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PX domain-containing protein 1 (PXDC1) is a protein-coding gene predicted to enable phosphatidylinositol binding activity, based on its domain structure[1][2]. It is not recognized as a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor[2]. PXDC1 has emerged in genomic imprinting research as a candidate for parent-of-origin-dependent gene expression, suggesting a role in the epigenetic regulation of gene expression and potentially diseases involving imprinting disruptions[1]. However, there is no established evidence that PXDC1 is directly involved in major signaling pathways, is a direct drug target, or serves as a standard biomarker. PXDC1 is also known by the alias C6orf145[1][2]. Its biological roles are under investigation, and its functions are not yet fully characterized in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PX domain-containing protein 1 (PXDC1).